James A. McNulty
Chief Financial Officer, BIODELIVERY SCIENCES INTERNATIONAL INC.
Companies
- Inhibitor Therapeutics, Inc.Chief financial officer May 16, 2024 to now1
- Lunai Bioworks Inc.Board member Oct 23, 2024 to Nov 6, 20242
- Inhibitor Therapeutics, Inc.Officer Dec 22, 2022 to May 17, 20233
- CV Sciences, Inc.Board member Apr 8, 2016 to Jun 18, 20204
- BIODELIVERY SCIENCES INTERNATIONAL INCSVP Finance & Treasurer Jan 28, 2014 to Feb 14, 20145
- BIODELIVERY SCIENCES INTERNATIONAL INCChief financial officer Feb 14, 2006 to Aug 19, 20136
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Inhibitor Therapeutics, Inc. INTI46,002,114 shares7$5.1M at $0.11Jul 1, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 1, 2026Gift 3,200,000 shares of Inhibitor Therapeutics, Inc.7
- Dec 2, 2024Gift 1,000,000 shares of Inhibitor Therapeutics, Inc.8
- May 5, 2023Other 20,101,057 shares of Inhibitor Therapeutics, Inc.9
- May 5, 2023Other 398,135 shares of Inhibitor Therapeutics, Inc.9
- May 5, 2023Other 79,627,069 shares of Inhibitor Therapeutics, Inc.9
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARLunai Bioworks Inc., Board member
- 3
- 4SEC EDGARCV Sciences, Inc., Board member
- 5
- 6
- 7
- 8SEC EDGARForm 5 filed Feb 19, 2025
- 9SEC EDGARForm 4 filed May 17, 2023